What role does CYP2D6 play in Blutzucker?

CYP2D6 is a cytochrome P450 enzyme primarily involved in drug metabolism, not directly in blood glucose regulation. The provided context contains no specific evidence linking CYP2D6 variants to blood sugar levels. Some indirect connections have been proposed – for example, CYP2D6 metabolizes neurotransmitters (serotonin, dopamine) and certain drugs (beta-blockers, antidepressants) that can affect glucose homeostasis – but these effects are weak, not consistently replicated, and not clinically actionable. Genetic testing for CYP2D6 is mainly used in pharmacogenetics to guide medication dosing, not to assess blood sugar. If you want to evaluate glycemic status, direct blood biomarkers (fasting glucose, HbA1c, insulin) are appropriate. The evidence for a role of CYP2D6 in blood sugar is mechanistic and unclear; no clinical recommendation can be derived from it.